Provider billing margin and cancer treatment selection: population based cohort study
In this observational study of Medicare beneficiaries, selection of cancer treatments was associated with the treatment's clinical benefit but not billing margin. Therefore, it is unlikely that policy and price changes that affect the billing margin of cancer treatments would shift patterns of use.
Authors
- Robert Michael Daly (ORCID: https://orcid.org/0000-0001-6573-7650)
- Aaron Philip Mitchell (ORCID: https://orcid.org/0000-0003-3639-3515)
- Nirjhar Chakraborty (ORCID: https://orcid.org/0009-0003-8104-4311)
- Grace Guzman
- Stacie B. Dusetzina (ORCID: https://orcid.org/0000-0002-3907-9196)
- Grace Gallagher (ORCID: https://orcid.org/0009-0004-9277-5002)
- Mithat Gönen (ORCID: https://orcid.org/0000-0001-8683-8477)
- Akriti Mishra Meza (ORCID: https://orcid.org/0000-0002-3477-5037)
- Sara Tabatabai (ORCID: https://orcid.org/0000-0002-5498-7176)
- Sonia Persaud (ORCID: https://orcid.org/0009-0008-5666-7994)
- Aaron N. Winn (ORCID: https://orcid.org/0000-0003-2906-3913)
- Andrew S. Epstein (ORCID: https://orcid.org/0000-0003-1808-3070)
- Victoria Blinder (ORCID: https://orcid.org/0000-0002-1448-8671)
- Hannah E. Fuchs (ORCID: https://orcid.org/0000-0003-2426-0096)
- Abdullah Abdelaziz (ORCID: https://orcid.org/0000-0002-5039-4322)
- Patrick Augello (ORCID: https://orcid.org/0009-0003-5897-3497)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- University of Pittsburgh (US)
- University of Illinois Chicago (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- BMJ
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1136/bmj-2025-084729
- Citations
- 1
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.13
Funders
- Commonwealth Fund
- Memorial Sloan-Kettering Cancer Center
- Arnold Ventures
- National Cancer Institute